Trends in the use of menopausal hormone therapy in France, 2001–2023
In France, the use of systemic MHT has plummeted since 2001, while use of local MHT has remained stable. Claims for local MHT now represent more than half of all MHT claims in France.
Authors
- Anne C. M. Thiébaut (ORCID: https://orcid.org/0000-0003-2651-2795)
- Manon Cairat (ORCID: https://orcid.org/0000-0002-0964-3120)
- A. Fournier (ORCID: https://orcid.org/0000-0001-8380-3439)
- E. Olivier (ORCID: https://orcid.org/0000-0001-8065-5792)
- R Costa
- Ana-Maria Vilcu
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Hôpital Paul-Brousse (FR)
Publication Details
- Journal
- Maturitas
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1016/j.maturitas.2025.108270
- Citations
- 1
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche